Abstract
Insulin-like growth factors (IGFs) play an important role in regulation of growth. Of the two major forms of IGFs, IGF-I is important for postnatal growth, whereas IGF-II is involved in fetal growth and development. These factors are synthesized in many different tissues and exert their physiological functions probably through an endocrine as well as an autocrine/paracrine mechanism of action. During the last years it has become clear that the autocrine/paracrine mechanism of action is probably more important than originally foreseen. Elegant studies of Han and others have revealed that connective tissues play an important role in production of IGF-I, but that the peptide subsequently accumulates in the adjacent tissues1,2. The hypothesis has been formulated that IGF levels in plasma regulate the overall growth status, while locally produced IGFs are important for cell proliferation in specific tissues (for reviews see 3,4). If this assumption is correct, balanced growth requires that the local production of IGFs is delicately controlled in a tissue-specific manner. We have established the gene structure for human IGF-I and -II and investigated the mechanisms involved in the expression of these genes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
V. K. M. Han, A. J. D’Ercole and P. K. Lund, Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus, Science 236:193 (1987).
V. K. M. Han, P. K. Lund, D. C. Lee and A. J. D’Ercole, Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization and tissue distribution, J. Clin. Endocrinol. Metab. 66:422 (1988).
W. H. Daughaday and P. S. Rotwein, Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations, Endocrine Reviews 10:68 (1989).
J. L. Van den Brande, Somatomedins on the move, Horm. Res. 32:58 (1990) .
M. Jansen, F. M. A. Van Schaik, A. T. Ricker, B. Bullock, K. H. Woods, D. E. Gabbay, A. L. Nussbaum, J. S. Sussenbach and J. L. Van den Brande, Sequence of cDNA encoding human insulin-like growth factor I precursor, Nature 306:609 (1983).
P. S. Rotwein, Two insulin-like growth factor I messenger RNAs are expressed in human liver, Proc. Natl. Acad. Sci. USA 83:77 (1986) .
M. Jansen, P. De Pagter-Holthuizen, F. M. A. Van Schaik, J. S. Sussenbach and J.L.Van den Brande, Characterization and organization of the somatomedin/insulin-like growth factor genes, in: “Somatomedins and other peptide growth factors: Relevance to Pediatrics,” R. L. Hintz and L. E. Underwood, eds. Report Eighty-Ninth Ross Conference on Pediatric Res. Ross Laboratories, Columbus,Ohio, pp 12 (1985).
M. Jansen, P. De Pagter-Holthuizen, J. W. M. Hoppener, J. S. Sussenbach and J. L. Van den Brande, Analysis of cDNA and mRNA encoding the somatomedin precursors, in: “Diabetes 1985’” M. Serrano-Rios and P . J. Lefebvre,eds., Elsevier Science Publishers B.V., Amsterdam, pp 289 (1986).
P. K. Lund, E. C. Hoyt and J. J. Van Wyk, The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3’-untranslated sequence, Mol.Endocrinol.3:2054 (1989).
J. W. M. Höppener, S. Mosselman, P. J. M. Roholl, C. Lambrechts, R. J. C. Slebos, P. De Pagter-Holthuizen, C. J. M. Lips, H. S. Jansz and J. S. Sussenbach, Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours, EMBO. J.7:1379 (1988).
C. T. Roberts Jr, S. R. Lasky, W. L. Lowe and D. Leroith, Rat IGF-I cDNAs contain multiple 5’-untranslated regions, Biochem. Biophys. Res. Commun. 14 6:1154 (1987).
W. L. Lowe, C. T. Roberts Jr, S. R. Lasky and D. Leroith, Differential expression of alternative 5’ untranslated regions in mRNAs encoding rat insulin-like growth factor I, Proc. Natl. Acad. Sci. USA 84:8946 (1987). .
P. De Pagter-Holthuizen, F. M. A. Van Schaik, G. M. Verduijn, G. J. B. Van Ommen, B. N. Bouma, M. Jansen and J. S. Sussenbach, Organization of the human genes for insulin-like growth factors I and II, FEBS Lett. 195:179 (1986).
P. De Pagter-Holthuizen, M. Jansen, R. A. van der Kammen, F. M. A. Van Schaik and J. S. Sussenbach, Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein, Biochim. Biophys. Acta 950:282 (1988).
P. Holthuizen, The structure and expression of the human insulin-like growth factor genes, in: “Molecular and cellular biology of insulin-like growth factors and their receptors,” D. Leroith and M. K. Raizada, eds., Plenum Press, New York, pp 97 (1989).
T. Ueno, K. Takahashi, T. Matsuguchi, H. Endo and M. Yamamoto, A new leader exon identified in the rat insulin-like growth factor II gene, Biochem. Biophys. Res. Commun. 148:344 (1987).
T. Matsuguchi, K. Takahashi, K. Ikejiri, T. Ueno, H. Endo and M. Yamamoto, Functional analysis of multiple promoters of the rat insulin-like growth factor II gene, Biochim. Biophys. Acta1048:165 (1990) .
L. Chiariotti, A. L. Brown, R. Frunzio, D. R. Clemmons, M. M. Rechler and C.B.Bruni, Structure of the rat insulin-like growth factor II transcripticnal unit: Heterogeneous transcripts are generated from two promoters by use of multiple polyadenylation sites and differential ribonucleic acid splicing, Mol. Endocrinol. 2:1115 (1988).
J. S. Sussenbach, The gene structure of the insulin-like growth factor family, Proqr. Growth Factor Res. 1:33 (1989).
J. Scott, J. Cowell, M. E. Robertson, L. M. Priestley, R. Wadey, B. Hopkins, J. Pritchard, G. I. Bell, L. B. Rall, C. F. Graham and T. J. Knott, Insulin-like growth factor II gene expression in Wilms’ tumour and embryonic tissue, Nature 317:260 (1985).
A. E. Reeve, M. R. Eccles, R. J. Wilkins, G. I. Bell and L. J. Millow, Expression of insulin-like growth factor II transcripts in Wilms’ tumour, Nature 317:258 (1985).
D. Yee, K. J. Cullen, S. Paik, J. F. Perdue, B. Hampton, A. Schwartz, M. E. Lippman and N. Rosen, Insulin-like growth factor II mRNA expression in human breast cancer, Cancer Res. 48:6691 (1988).
T. S. Su, W. Y. Liu, S. H. Han, M. Jansen, T. L. Yang-Fen, F. K. P’eng and C. K. Chou, Transcripts of the insulin-like growth factors I and II in human hepatoma, Cancer Res. 49:1773 (1989).
W. L. Lowe, C. T. Roberts Jr, D. Leroith, M. T. Rojeski, T. J. Merimee, S. T. Fui, H. Keen, D. Arnold, J. Mersey, S. Gluzman, D. Spratt, R. C. Eastman and J. Roth, Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: Increased levels of messenger ribonucleic acid, J. Clin. Endocrinol. Metab. 69:1153 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Sussenbach, J.S. et al. (1991). Structural and Regulatory Aspects of the Human Genes Encoding IGF-I and -II. In: Raizada, M.K., LeRoith, D. (eds) Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Advances in Experimental Medicine and Biology, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5949-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5949-4_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5951-7
Online ISBN: 978-1-4684-5949-4
eBook Packages: Springer Book Archive